Genentech, Inc. v. Sandoz, Inc. – Esbriet® (Pirfenidone)

Case Name: Genentech, Inc. v. Sandoz, Inc., Civ No. 23-4085 (JXN)(LDW), 2024 WL 939692 (D.N.J. Mar. 5, 2024) (Wettre, M.J.) – Drug Product and Patent(s)-in-Suit: Esbriet® (pirfenidone); U.S. Patent No. 10,118,637 (“the ’637 patent”)….
By: Robins Kaplan LLP
Previous Story

Chairs of House and Senate Commerce Committees Announce Consumer Privacy Legislation

Next Story

Data Privacy + Cybersecurity Insider – May 2024